42Stockpicking

BMY

Bristol Myers SquibbKøb· 74.1%· 25. aug. 2026
NYSE·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
19,6
36th %ile · 62p
EV/EBITDAi
—
P/Bi
7,5
71st %ile · 64p
P/Si
2,9
42nd %ile · 70p
EV/Salesi
3,8
51st %ile · 70p
Div yieldi
3,7 %
94th %ile · 39p

Regnskabsdata (SEC EDGAR)

Årsregnskab (senest 5 år)

FY 2025FY 2024FY 2023FY 2022FY 2021
Omsætning48.194,0 mio.48.300,0 mio.45.006,0 mio.46.159,0 mio.46.385,0 mio.
Bruttoresultat—————
Nettoresultat7.054,0 mio.-8.948,0 mio.8.025,0 mio.6.327,0 mio.6.994,0 mio.
Op. cash flow14.156,0 mio.15.190,0 mio.13.860,0 mio.13.066,0 mio.16.207,0 mio.
Capex1.311,0 mio.1.248,0 mio.1.209,0 mio.1.118,0 mio.973,0 mio.
Free cash flow12.845,0 mio.13.942,0 mio.12.651,0 mio.11.948,0 mio.15.234,0 mio.
EPS3,47-4,413,882,973,15
Aktiver i alt90.038,0 mio.92.603,0 mio.95.159,0 mio.96.820,0 mio.109.314,0 mio.
Egenkapital18.473,0 mio.16.335,0 mio.29.430,0 mio.31.061,0 mio.35.946,0 mio.
Rentebærende gæld46.804,0 mio.102.518,0 mio.84.798,0 mio.85.700,0 mio.98.266,0 mio.
Aktier udestående2.039,0 mio.2.027,0 mio.2.078,0 mio.2.146,0 mio.2.245,0 mio.

Kvartalsregnskab (senest 4 kvartaler)

Q3 2025Q2 2025Q1 2025Q4 2024
Omsætning35.692,0 mio.23.470,0 mio.11.201,0 mio.—
Bruttoresultat————
Nettoresultat5.967,0 mio.3.766,0 mio.2.456,0 mio.—
Op. cash flow12.182,0 mio.5.871,0 mio.1.954,0 mio.—
Capex941,0 mio.621,0 mio.260,0 mio.—
Free cash flow11.241,0 mio.5.250,0 mio.1.694,0 mio.—
EPS2,931,851,21—
Aktiver i alt96.889,0 mio.94.676,0 mio.92.427,0 mio.92.603,0 mio.
Egenkapital18.552,0 mio.17.435,0 mio.17.389,0 mio.16.335,0 mio.
Rentebærende gæld52.965,0 mio.53.420,0 mio.52.855,0 mio.153.777,0 mio.
Aktier udestående2.039,0 mio.2.039,0 mio.2.040,0 mio.—